PARSOL 1789 TESTING WITH POSSIBLE INGREDIENT COMBINATIONS IS NOT WARRANTED
This article was originally published in The Tan Sheet
Executive Summary
PARSOL 1789 TESTING WITH POSSIBLE INGREDIENT COMBINATIONS IS NOT WARRANTED by the monograph regulations or by FDA policy guidelines, Givaudan-Roure Counsel Edward Basile of the Washington D.C. firm King & Spalding contended in a May 13 letter to FDA that follows up on a May 11 "OTC feedback" meeting ("The Tan Sheet" May 16, p. 20).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning